Behind the Novo Nordisk we know today lies an exciting story that goes back more than 90 years. It began with the two small Danish companies, Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium, founded in 1923 and 1925, respectively. The two companies started the production of the revolutionary new drug insulin that had just been discovered by two Canadian scientists.
Since the earliest days, both Nordisk and Novo focused on the development of products to benefit people with diabetes. Competing intensely with one another, the companies developed into two of the best in their field. When at last they decided to merge in 1989, they created Novo Nordisk, a company that has been expanding rapidly ever since with leading positions within diabetes care, hemophilia care, growth hormone therapy and hormone replacement therapy.
Today the Novo Nordisk Way shows responsibility to patients, employees, communities and investors.
We will in the future continue to build on the legacy left by the founders of Novo Nordisk and do whatever it takes to change diabetes, obesity, hemophilia and growth hormone deficiency. Our history tells us it can be done.
Read about the founders:
August & Marie Krogh, Hans Christian Hagedorn, August Kongsted and Harald & Thorvald Pedersen.